secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001493152-26-020939
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity exchanges common, options, warrants for Series C preferred with 40 votes per share
--------------------------------------------------------------------------------

- 14.14M common shares, 3.99M options, and 1.44M warrants exchanged for 1.96M Series C shares at a 10:1 ratio.
- Series C carries 40 votes per share; converts into 59.6% of common upon a $15M+ qualified financing.
- If no qualified financing by March 31, 2028, each Series C converts to 10 common shares.
- Exchange holders include officers and directors; transaction is exempt under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315226020939/0001493152-26-020939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315226020939/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-020939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer